This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Dnanexus, Inc. for the procurement of the DnaNexus bioinformatic cloud computing platform license and support. The total potential value of the contract is $120,000.00, and the period of performance will end on September 18, 2024. The contract does not have a set-aside designation. Dnanexus, Inc. will provide cloud-based genomics...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed-price purchase order contract to Dnanexus, Inc. for a "Biobank Research Analysis Platform." The $12,569.50 contract does not have a set-aside designation and is for the delivery of cloud-based genomics data management and analysis services from Dnanexus, a for-profit organization. Through this award, Dnanexus will provide bioinformatics software,...
This is a federal contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit company providing cloud-based genomics data management and analysis services. The contract, titled "A Cloud Platform for Evaluating NGS-Based Diagnostic Test Pipelines," has a ceiling value of $1,993,255.79 and runs through April 27, 2018. The contract is a definitive contract with a firm fixed price pricing type. Dnanexus has previously held other federal contracts with the FDA...
This federal contract award, ID 75N95D25P00053, was issued by the National Institute on Aging, a civilian agency, to Dnanexus, Inc., a for-profit company headquartered in Mountain View, California. The $14,000 firm-fixed-price purchase order is for computing infrastructure providers, data processing, web hosting, and related services to access and utilize the Research Analysis Platform (RAP) for the analysis and storage of large-scale deidentified datasets. This contract is not set aside for...
This federal contract award was granted by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit corporate entity based in Mountain View, California. The $6,755,725.98 Firm Fixed Price Delivery Order contract is for Dnanexus to provide the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists to enable collaboration on regulatory science and precision medicine...
This is a $15,000,000.00 Other Transaction Agreement (OTA) awarded by the National Institutes of Health (NIH) to Dnanexus, Inc., a for-profit technology company headquartered in Mountain View, California. The contract, titled "ADAPT - ADVANCED ANALYSIS FOR PRECISION CANCER THERAPY TREATMENT AND ANALYSIS PLAN (TAP)," does not have a set-aside designation. The contract is focused on providing cloud-based genomics data management and analysis services to support precision medicine...
This is a $1,051,402.26 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The contract is for the development of a PRISM high-impact platform pilot to support pre-submission validation of electronic common technical documents (eCTDs) and sponsor-reviewer interaction. This contract is not set aside for small businesses, and Dnanexus has been...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
This firm-fixed-price delivery order for $631,840.53 was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The award is for Phase III of the FY24 Common Data Harmonization System, a project to develop and maintain cloud-based platforms that support collaboration between researchers and regulatory reviewers, as well as genomic data analysis environments. Dnanexus has...
This is a delivery order awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company based in Mountain View, California. The contract, valued at $473,879.68, is for the operation and maintenance of the PrecisionFDA public instance of the Genomics Sequence and Regulatory Science (GSRS) platform. PrecisionFDA is a cloud-based genomics data management and analysis platform that enables collaboration between researchers and regulatory reviewers. This delivery...